Quanterix Corporation (QTRX)

NASDAQ: QTRX · Real-Time Price · USD
6.21
-0.51 (-7.59%)
At close: Apr 3, 2025, 4:00 PM
6.00
-0.21 (-3.38%)
Pre-market: Apr 4, 2025, 4:11 AM EDT
-7.59%
Market Cap 240.80M
Revenue (ttm) 137.42M
Net Income (ttm) -38.53M
Shares Out 38.78M
EPS (ttm) -1.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 423,088
Open 6.45
Previous Close 6.72
Day's Range 6.16 - 6.46
52-Week Range 6.16 - 22.59
Beta 1.35
Analysts Strong Buy
Price Target 18.25 (+193.88%)
Earnings Date May 6, 2025

About QTRX

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of ... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Dec 7, 2017
Employees 471
Stock Exchange NASDAQ
Ticker Symbol QTRX
Full Company Profile

Financial Performance

In 2024, Quanterix's revenue was $137.42 million, an increase of 12.30% compared to the previous year's $122.37 million. Losses were -$38.53 million, 35.9% more than in 2023.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for QTRX stock is "Strong Buy." The 12-month stock price forecast is $18.25, which is an increase of 193.88% from the latest price.

Price Target
$18.25
(193.88% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the inclusion of a new dried...

3 days ago - Business Wire

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

CHARLOTTE, N.C.--(BUSINESS WIRE)--Tikvah Management LLC (together with its affiliates, “Tikvah” or “we”), which owns approximately 1.5% of the outstanding common shares of Quanterix Corp. (Nasdaq: QTR...

Other symbols: AKYA
10 days ago - Business Wire

Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript

Quanterix Corporation (NASDAQ:QTRX) Q4 2024 Earnings Conference Call March 17, 2025 4:30 PM ET Company Participants Joshua Young - Head of IR Masoud Toloue - President and CEO Vandana Sriram - CFO Co...

17 days ago - Seeking Alpha

Quanterix Releases Financial Results for the Fourth Quarter of 2024

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the f...

17 days ago - Business Wire

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

RINCON, Puerto Rico--(BUSINESS WIRE)--Kent Lake PR LLC (“Kent Lake”) is a holder of 7.47% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX). Kent L...

Other symbols: AKYA
17 days ago - Business Wire

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conferen...

21 days ago - Business Wire

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

RINCON, Puerto Rico--(BUSINESS WIRE)--Kent Lake PR LLC (“Kent Lake”) a holder of 7.25% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), today iss...

Other symbols: AKYA
23 days ago - Business Wire

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

RINCON, Puerto Rico--(BUSINESS WIRE)--Kent Lake PR LLC (“Kent Lake”), a holder of 6.9% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), announced...

4 weeks ago - Business Wire

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX) (“Quanterix” or the “Company”), a company fueling scientific discovery through ultra-sensitive biomarker detection, today reiter...

4 weeks ago - Business Wire

The Schall Law Firm Invites Shareholders With Losses In Quanterix Corporation To Join A Securities Fraud Investigation

LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Co...

4 weeks ago - Accesswire

Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer's Disease

Neurogen Biomarking's Brain Health Care Ecosystem Gives Patients Easier Access to Clinically Validated Blood Biomarker Technology Neurogen Biomarking's Brain Health Care Ecosystem Gives Patients Easie...

6 weeks ago - GlobeNewsWire

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences

RINCON, Puerto Rico--(BUSINESS WIRE)--Kent Lake PR LLC (“Kent Lake”), a holder of 5.9% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), today hig...

Other symbols: AKYA
6 weeks ago - Business Wire

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Quanterix Corporat...

6 weeks ago - GlobeNewsWire

Quanterix Investor News: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Quanterix Corporat...

2 months ago - GlobeNewsWire

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Quanterix Corporation For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix...

2 months ago - Accesswire

Bragar Eagel & Squire, P.C. Is Investigating Quanterix and TransMedics and Encourages Investors to Contact the Firm

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Quanterix Corporation (NASDAQ:QT...

Other symbols: TMDX
2 months ago - GlobeNewsWire

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Quanterix Corporation For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 28, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix...

2 months ago - Accesswire

Quanterix Provides Update on Financial Performance

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced selected preliminary, unaudi...

2 months ago - Business Wire

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Akoya Bioscience...

Other symbols: AKYA
2 months ago - Business Wire

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

BILLERICA, Mass. and MARLBOROUGH, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Bioscience...

Other symbols: AKYA
2 months ago - Business Wire

David R. Walt Receives National Medal of Technology and Innovation

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that David R. Walt, co-inven...

3 months ago - Business Wire

Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Exe...

3 months ago - Business Wire

The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Quanterix Corporation For Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / December 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Cor...

3 months ago - Accesswire

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Quanterix Corporation For Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / December 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Cor...

3 months ago - Accesswire

The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Quanterix Corporation For Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / December 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Cor...

3 months ago - Accesswire